Hypothesis and Theory

Published on 17 Jan 2023

Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach

in Nuclear Medicine

Asta Juzeniene
Vilde Yuli Stenberg
Øyvind Sverre Bruland
Mona-Elisabeth Revheim
Roy Hartvig Larsen

Frontiers in Medicine

doi 10.3389/fmed.2022.1051825

4,256 views
6 citations

Mini Review

Published on 09 Jan 2023

Targeted thorium-227 conjugates as treatment options in oncology

in Nuclear Medicine

Jenny Karlsson
Christoph A. Schatz
Antje M. Wengner
Stefanie Hammer
Arne Scholz
Alan Cuthbertson
Volker Wagner
Hartwig Hennekes
Vicki Jardine
Urs B. Hagemann

Frontiers in Medicine

doi 10.3389/fmed.2022.1071086

5,858 views
12 citations

Review

Published on 06 Jan 2023

Astatine-211 based radionuclide therapy: Current clinical trial landscape

in Nuclear Medicine

Per Albertsson
Tom Bäck
Karin Bergmark
Andreas Hallqvist
Mia Johansson
Emma Aneheim
Sture Lindegren
Chiara Timperanza
Knut Smerud
Stig Palm

Frontiers in Medicine

doi 10.3389/fmed.2022.1076210

16,020 views
32 citations

Original Research

Published on 05 Jan 2023

Performance characteristics of 18F–fluorodeoxyglucose in non-infected hip replacement

in Nuclear Medicine

Yiqun Wang
Lulu Yuan
Yinqiao Du
Honghong Liu
Qingxiao Li
Yan Chang
Yuanyuan Shi
Yanmei Wang
Xiaolin Meng
Yonggang Zhou

Frontiers in Medicine

doi 10.3389/fmed.2022.1043812

2,672 views

Brief Research Report

Published on 04 Jan 2023

Clinical imaging of primary pulmonary nucleoprotein of the testis carcinoma

in Nuclear Medicine

Wenpeng Huang
Yongbai Zhang
Qi Yang
Ge Gao
Yongkang Qiu
Liming Li
Lei Kang

Frontiers in Medicine

doi 10.3389/fmed.2022.1083206

1,514 views

Review

Published on 04 Jan 2023

Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [223Ra]RaCl2 and [224Ra]RaCl2

in Nuclear Medicine

Michael Lassmann
Uta Eberlein

Frontiers in Medicine

doi 10.3389/fmed.2022.1057373

4,044 views
2 citations

Mini Review

Published on 22 Dec 2022

Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer

in Nuclear Medicine

Joe M. O’Sullivan
Rana R. McKay
Kambiz Rahbar
Karim Fizazi
Daniel J. George
Bertrand Tombal
Anja Schmall
Per Sandström
Frank Verholen
Neal Shore

Frontiers in Medicine

doi 10.3389/fmed.2022.1070392

5,493 views
5 citations

Review

Published on 22 Dec 2022

Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?

in Nuclear Medicine

Roger M. Pallares
Rebecca J. Abergel

Frontiers in Medicine

doi 10.3389/fmed.2022.1020188

14,359 views
27 citations

Case Report

Published on 20 Dec 2022

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT

in Nuclear Medicine

Karim Amrane
Coline Le Meur
Philippe Thuillier
Pierre Alemany
Clémence Niel
David Renault
Ronan Abgral

Frontiers in Medicine

doi 10.3389/fmed.2022.1078560

2,055 views
3 citations

Review

Published on 16 Dec 2022

Targeted alpha therapy for glioblastoma

in Nuclear Medicine

Jolanta Kunikowska
Alfred Morgenstern
Kacper Pełka
Frank Bruchertseifer
Leszek Królicki

Frontiers in Medicine

doi 10.3389/fmed.2022.1085245

4,829 views
10 citations

Editorial

Published on 12 Dec 2022

Editorial: Small animal imaging: Technological and methodological advances to improve the translational power

in Nuclear Medicine

Monique R. Bernsen
Wendy McDougald
Laura Mezzanotte
Carmel M. Moran
Adriana Tavares
Louise van der Weerd

Frontiers in Medicine

doi 10.3389/fmed.2022.1099233

1,097 views

Review

Published on 07 Dec 2022

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists

in Nuclear Medicine

Mengqi Shi
Vivianne Jakobsson
Lukas Greifenstein
Pek-Lan Khong
Xiaoyuan Chen
Richard P. Baum
Jingjing Zhang

Frontiers in Medicine

doi 10.3389/fmed.2022.1034315

12,811 views
28 citations

Review

Published on 06 Dec 2022

Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts

in Nuclear Medicine

Oliver Sartor
Ali Baghian

Frontiers in Medicine

doi 10.3389/fmed.2022.1060922

6,436 views
11 citations

Brief Research Report

Published on 02 Dec 2022

Exploratory analysis of radiomic as prognostic biomarkers in 18F-FDG PET/CT scan in uterine cervical cancer

in Nuclear Medicine

Nadja Rolim Gonçalves de Alencar
Marcos Antônio Dórea Machado
Felipe Alves Mourato
Mércia Liane de Oliveira
Thauan Fernandes Moraes
Luiz Alberto Reis Mattos Junior
Tien-Man Cabral Chang
Carla Rameri Alexandre Silva de Azevedo
Simone Cristina Soares Brandão

Frontiers in Medicine

doi 10.3389/fmed.2022.1046551

2,423 views
7 citations

Editorial

Published on 02 Dec 2022

Editorial: Case reports in PET imaging

in Nuclear Medicine

Silvia Taralli
Natale Quartuccio
Gaurav Malviya

Frontiers in Medicine

doi 10.3389/fmed.2022.1087583

1,348 views

Brief Research Report

Published on 02 Dec 2022

Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease

in Nuclear Medicine

Cecilia Boccalini
Giulia Carli
Emilia Giovanna Vanoli
Antoniangela Cocco
Alberto Albanese
Valentina Garibotto
Daniela Perani

Frontiers in Medicine

doi 10.3389/fmed.2022.1073720

1,671 views
3 citations

Navigation group

Articles

Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach

Targeted thorium-227 conjugates as treatment options in oncology

Astatine-211 based radionuclide therapy: Current clinical trial landscape

Performance characteristics of 18F–fluorodeoxyglucose in non-infected hip replacement

Clinical imaging of primary pulmonary nucleoprotein of the testis carcinoma

Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [223Ra]RaCl2 and [224Ra]RaCl2

Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer

Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT

Targeted alpha therapy for glioblastoma

Editorial: Small animal imaging: Technological and methodological advances to improve the translational power

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists

Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts

Exploratory analysis of radiomic as prognostic biomarkers in 18F-FDG PET/CT scan in uterine cervical cancer

Editorial: Case reports in PET imaging

Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease